. home.aspx

home.aspx
   

Why is pharma so bad at sharing clinical trial data?

October 21, 2019 / ABI MILLAR

Since the 90s, the requirements for pharmaceutical companies to register and report results from clinical trials have increased. But analysis published in the BMJ indicates that large pharmaceutical companies could be doing much more when it comes to sharing data. Over the last few decades, pharma companies have been under ever-mounting pressure to report their clinical trial data. Beginning in 1997, when the US Food and Drug Administration (FDA) required certain trials to be registered, the expectations for transparency have steadily increased.